Selected article for: "cell line and ectopic expression"

Author: Richard, A; Tulasne, D
Title: Caspase cleavage of viral proteins, another way for viruses to make the best of apoptosis
  • Document date: 2012_3_8
  • ID: 3hxau5vt_10
    Snippet: Kaposi sarcoma-associated herpesvirus (KSHV) establishes long-term infections leading to Kaposi sarcomas and can go through either latent or lytic cycle. When KSHV is reactivated, ORF57 (or Mta or KS-SM) is detected by western blot as a doublet, 30 with the smaller product being abolished by a pan caspase inhibitor. In vitro, caspase 7, which is activated on KSHV reactivation, and to a lesser extent caspases 5 and 10, are able to process ORF57 at.....
    Document: Kaposi sarcoma-associated herpesvirus (KSHV) establishes long-term infections leading to Kaposi sarcomas and can go through either latent or lytic cycle. When KSHV is reactivated, ORF57 (or Mta or KS-SM) is detected by western blot as a doublet, 30 with the smaller product being abolished by a pan caspase inhibitor. In vitro, caspase 7, which is activated on KSHV reactivation, and to a lesser extent caspases 5 and 10, are able to process ORF57 at 30 DETD 33 k. Interestingly, coexpression assays show that ORF57 cleavage product (i.e. ORF57 lacking residues 1-33) is no longer able to promote viral lytic gene expression. Accordingly, complementing a stable cell line containing an orf57-null KSHV genome with ectopic WT or uncleavable ORF57 promotes lytic gene expression, while ORF57 lacking residues 1-33 does not. Consistently, the number of cell-free virus particles dramatically increases when caspase 7 is inhibited. Thus, ORF57 cleavage would prevent proper expression of its downstream targets and subsequent full reactivation of KSHV, suggesting that it allows KSHV to maintain a persistent infection.

    Search related documents:
    Co phrase search for related documents
    • cell free virus and gene expression: 1
    • cell line and cleavage product: 1
    • cell line and downstream target: 1, 2, 3
    • cell line and gene expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cleavage product and gene expression: 1, 2, 3, 4
    • downstream target and gene expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • dramatically increase and gene expression: 1, 2
    • gene expression and Kaposi sarcoma: 1, 2, 3
    • gene expression and KSHV reactivation: 1, 2, 3, 4, 5
    • gene expression and less extent: 1